Doozio
Posted - 16 hours ago
$olma god every $xbi STOK wants TTWO $asnd in HRMY wen da FATE of da YO is protected by its 😇 in 🧠⏰♾️
StockAuthority
Posted - 1 week ago
$UNCY we gonna make people more money! $ASND $MGOL $UNCY
PCtrader20
Posted - 1 week ago
$ASND $MGOL $UNCY so far I am 3 of 3 with your picks so far. Let see if this one will make it 4 of 4
StockAuthority
Posted - 1 week ago
$UNCY my next $MGOL 1000% winner right here, like also $ASND and $MLOG went. NDA news any day now, at least a few hundo % move coming imo, they have an $8 price target on it too 1600% higher 🔥
Doozio
Posted - 1 week ago
Once da huckleberries arrive da 🧠 shall $asnd in 🧠⏰
Night_Owl_Biotech
Posted - 1 week ago
Using $JAZZ analyst consensus revenue estimates, the video (link below) calculates what JAZZ would be worth if acquired at the same cumulative 10-year revenue multiple $SNY paid when it acquired Bioverativ back in Q1 2018. We cannot be sure JAZZ analyst consensus revenue estimates are credible nor can we be sure the Sanofi/Bioverativ M&A transaction is an appropriate peer to estimate JAZZ value. This is only a what-if analysis but does suggest JAZZ management should consider their own like analysis to ensure shareholder value is maximized. This is not investment advice. The $XBI trades for roughly the same price today (or as of 7/9/24 when the analysis was prepared) as it did when Sanofi announced it was buying Bioverativ. As always, we could be very wrong. We are only asking the question. $ASND $AXSM are next Link to YouTube video: https://www.youtube.com/watch?v=fQMLS_OvIp8
PeedyWeedy
Posted - 2 weeks ago
$ASND What’s to expect on pdufa the 14th here? A big move?
Doozio
Posted - 2 weeks ago
The amount of proper bases in $xbi ready TTWO $asnd in 🧠⏰♾️?
Doozio
Posted - 2 weeks ago
Wen da huckleberries arrive da 🧠 shall $asnd in 🧠⏰♾️
tymtested
Posted - 06/29/24
$ASND Frequently, stocks trade for about 70% of price targets until real cash flow and profitability occur.
SmokeTheBears
Posted - 4 weeks ago
$ASND is this stock ticker halted or something. Hasn’t moved for the last 10-15 minutes. ??
briefingcom
Posted - 1 month ago
$ASND: Ascendis Pharma upgraded to Buy from Hold at TD Cowen; tgt raised to $175 https://www.briefing.com/calendars/updown?Filter=Upgrades
DonCorleone77
Posted - 1 month ago
$ASND Ascendis Pharma presents data from Phase 2 ACcomplisH Trial of TransCon CNP Ascendis Pharma announced the oral presentation of data from its Phase 2 ACcomplisH Trial of TransCon CNP in children aged 2 to 10 years old with achondroplasia by Ravi Savarirayan, M.D., Murdoch Children's Research Center, during ICCBH 2024, the International Conference on Children's Bone Health being held in Salzburg, Austria. The data showed that patients treated for one year at the pivotal 100undefined/kg/week dose demonstrated significant improvements in well-being and physical functioning compared to placebo. These improvements could not be explained by changes in linear growth only, supporting a potential additional direct treatment effect of TransCon CNP beyond linear growth.
Stock_Titan
Posted - 1 month ago
$ASND Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Achondroplasia Presented at ICCHBH 2024
https://www.stocktitan.net/news/ASND/data-from-phase-2-a-ccomplis-h-trial-of-trans-con-cnp-in-children-ugdj34x7r8rw.html
tymtested
Posted - 1 month ago
$ASND playground for manipulators and traders
Pika_Capital
Posted - 1 month ago
$APGE $KROS $ASND either of these will be bought out within year or so for at least 100% premium
tymtested
Posted - 1 month ago
$ASND any recent insider buys?
DonCorleone77
Posted - 1 month ago
$ASND Ascendis presents new data/results of Phase 1/2 IL-Believe Trial at ASCO Ascendis Pharma reported new and updated results from its ongoing Phase 1/2 IL-Believe Trial of TransCon IL-2 ss/? in a poster presentation at ASCO 2024, the annual meeting of the American Society of Clinical Oncology being held in Chicago May 31-June 4. Data included the first presentation of Phase 2 dose expansion Cohort 4 in post anti-PD-1 melanoma and new analyses of patients from dose escalation cohorts with prior disease progression on checkpoint inhibitors, along with biomarker studies correlating cytotoxic immune cell expansion and clinical benefit. As of the April 16, data cutoff, confirmed clinical responses were observed in 40% of efficacy-evaluable patients from Cohort 4, suggesting potential synergy of Ascendis Pharma's two novel immunotherapy agents."We are very encouraged by the clinical response and safety profile for TransCon IL-2 ss/? and are pleased to see it working as designed to recruit and amplify the body's immune response with sustained immune activation without a corresponding increase in markers of toxicity," said Stina Singel, M.D., Ph.D., Ascendis Pharma's Executive Vice President and Head of Clinical Development, Oncology. "These new data in a heavily pre-treated population who progressed on or did not benefit from prior checkpoint inhibitors support TransCon IL-2 ss/? as the first biased IL-2 cytokine therapy to show not only monotherapy activity in a convenient outpatient setting every 3 weeks but also a direct correlation between clinical benefit and expansion of CD8+ T cells. We look forward to additional data readouts expected later this year from larger, indication-specific cohorts."
Stock_Titan
Posted - 1 month ago
$ASND Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
https://www.stocktitan.net/news/ASND/ascendis-pharma-presents-new-data-and-updated-results-from-phase-1-2-qmd7pklhditi.html
Stock_Titan
Posted - 05/30/24
$ASND Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
https://www.stocktitan.net/news/ASND/ascendis-to-spotlight-latest-updates-for-trans-con-rare-sebh70crnmtv.html
JackDarwin
Posted - 05/30/24
$ASND Nice Bullish Engulfing Formed.
WitzKash
Posted - 05/29/24
$ASND
Pika_Capital
Posted - 2 months ago
$ASND double if you listened to pika but you should NOT
If I had to think what would be relatively easy double elsewhere in bios I'd probably say $ACAD at $15 and $TGTX but may take year, two
Pika_Capital
Posted - 2 months ago
$asnd what's cooking on higher volume here
tymtested
Posted - 2 months ago
$ASND Seriously, I would like to see Morgan Stanley's financial equation that results in a price target of $140.
tymtested
Posted - 2 months ago
$ASND how does the market generate a market cap of $7B! with this financial picture??
tymtested
Posted - 2 months ago
$ASND This stock price is already so high that even a near term catalyst cant move it up. losing huge money each quarter and forecast to continue doing so in the foreseeable future. Now the FDA gives it a gut punch.
Aigner_Andreas
Posted - 2 months ago
TD BUY $ASND at 124.04, Supp 124.04 Resis 141.10 R14 HiLo 52% T1Y 151 buy 1.6 DIV N/A #Ascendis P #stocks #trading #finance #market
Pika_Capital
Posted - 2 months ago
$asnd I'm lightening my position a bit. Don't want to be caught pants down when if they get CRL in August
